While not every patient with AML develops skin involvement, it can be one of the earliest visible signs that something systemic is occurring.

Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...

Researchers have identified a molecular pathway involving succinate and the SUCNR1 receptor that may help prevent stem cells from turning cancerous, offering a potential new target for treating ...

Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

The study, titled “Epigenetic regulation of non-canonical menin targets modulates menin inhibitor response in acute myeloid leukemia,” was recently published in Blood and focuses on acute myeloid ...

Trial investigates macrophage re-reprogramming immunotherapy bexmarilimab in combination with azacitidine to prevent relapse in MRD-positive AML after stem cell transplantation. TURKU, FI / ACCESS ...

An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. Researchers at Baylor College of Medicine, University of Veterinary ...